Sitemap  

  
Home Page About ISMP ISMP Medication Safety Newsletters Teleconferences ISMP Message Board Report Medication Errors to ISMP ISMP Online Store Consulting Services Support ISMP FAQ Contact Us

Textbook and Publication Errata

Hazard Warning

From the May 21,1997 Issue

The latest edition of the widely used text, Cancer: Principles and Practice of Oncology, lists a chemotherapy regimen in a manner that could lead to a fatal overdose. In the EPOCH regimen in table 44.6-12 on page 2272, doses are listed as:

etoposide 200mg/m2 IV infusion days 1 to 4
vincristine 1.6mg/m2 IV infusion days 1 to 4
doxorubicin 40mg/m2 IV infusion days 1 to 4

 

Cyclophosphamide and prednisone are also included in the regimen.
This method of dose expression is ambiguous. The doses for etoposide, vincristine, and doxorubicin are course doses which are supposed to be given as a continuous IV infusion over a four-day period. Similarly expressed doses have led to errors in which the entire course dose was administered daily for 4 days. This type of error has happened many times, including the well known incident in Boston 1995. Instead, the regimen for etoposide, vincristine and doxorubicin should state:

etoposide 50mg/m2/day IV infusion days 1 to 4
vincristine 0.4mg/m2/day IV infusion days 1 to 4
doxorubicin 10mg/m2/day IV infusion days 1 to 4

Please inform relevant staff and make revisions in library texts at your location. The publisher, J.B. Lippincott, has been informed by ISMP.

 

Home  |  Contact Us  |  Employment  |  Legal Notices  |  Contact Webmaster
Med-E.R.R.S.  |   ISMP Canada  |   ISMP Spain  |  Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044
Phone: (215) 947-7797,  Fax: (215) 914-1492

© 2008 Institute for Safe Medication Practices. All rights reserved